The effect of sodium/glucose cotransporter 2 (SGLT2) inhibition on the urinary proteome

• David Cherney,

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Writing – original draft, Writing – review & editing

  Affiliation Division of Nephrology, University Health Network, University of Toronto, Toronto, Canada

  ⨯
• Bruce A. Perkins,

  Roles Conceptualization, Data curation, Investigation, Writing – original draft, Writing – review & editing

  Affiliation Division of Endocrinology, University Health Network, University of Toronto, Toronto, Canada

  ⨯
• Yuliya Lytvyn,

  Roles Investigation, Writing – original draft, Writing – review & editing

  Affiliation Division of Nephrology, University Health Network, University of Toronto, Toronto, Canada

  ⨯
• Hiddo Heerspink,

  Roles Writing – original draft, Writing – review & editing

  Affiliation Department of Clinical Pharmacology University Medical Center Groningen, Groningen, the Netherlands

  ⨯
• María E. Rodríguez-Ortiz,

  Roles Formal analysis, Writing – original draft, Writing – review & editing

  Affiliation Instituto de Investigación Sanitaria Fundación Jiménez Díaz. Fundación Renal Iñigo Álvarez de Toledo. Universidad Autónoma de Madrid. REDinREN, Madrid, Spain

  ⨯
• Harald Mischak

  Roles Conceptualization, Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review & editing

  * E-mail: mischak@mosaiques-diagnostics.com

  Affiliations Mosaiques diagnostics GmbH, Hanover, Germany, BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom

  http://orcid.org/0000-0003-0323-0306

  ⨯